With 5.2 million shares changed hands, the volume of the stock remained heavier than its average volume of 4.17 million shares. During the session, the Uranium company that operates in wider Energy sector, reached to the highest price of $51.56 whereas the lowest price it dropped to was $49.55. The 52-week range on CCJ shows that it touched its highest point at $62.55 and its lowest point at $35.43 during that stretch. It currently has a 1-year price target of $59.62. With its current market cap of 22.36 billion, CCJ has annualized dividend of $0.11 while the current yield stands at 0.22%. Beta for the stock currently stands at 0.94.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CCJ was down-trending over the past week, with a drop of -0.02%, but this was down by -15.85% over a month. Three-month performance dropped to -0.39% while six-month performance fell -4.36%. The stock gained 20.30% in the past year, while it has lost -0.02% so far this year. A look at the trailing 12-month EPS for CCJ yields 0.20 with Next year EPS estimates of 1.17. For the next quarter, that number is 0.23. This implies an EPS growth rate of -25.54% for this year and 170.97% for next year. EPS is expected to grow by 65.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 13.73%.
Float and Shares Shorts:
At present, 435.18 million CCJ shares are outstanding with a float of 433.32 million shares on hand for trading. On 2024-12-13, short shares totaled 18.46 million, which was 385.0 higher than short shares on 1731628800. In addition to Mr. Timothy S. Gitzel as the firm’s President, CEO & Director, Dr. Grant E. Isaac Ph.D. serves as its Executive VP & CFO.
Institutional Ownership:
Through their ownership of 0.74389 of CCJ’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, CCJ reported revenue of $720596000.0 and operating income of $100984000.0. The EBITDA in the recently reported quarter was $140763000.0 and diluted EPS was $0.02.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CCJ since 5 analysts follow the stock currently. There are 5 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With CCJ analysts setting a high price target of 100.487 and a low target of 81.525, the average target price over the next 12 months is 88.4068. Based on these targets, CCJ could surge 95.58% to reach the target high and rise by 58.67% to reach the target low. Reaching the average price target will result in a growth of 72.06% from current levels.
Analysts have provided yearly estimates in a range of $0.75365 being high and $0.47851 being low. For CCJ, this leads to a yearly average estimate of $0.6101.
